Dr. Reddy’s Laboratories Reports Q3 FY ’26 Revenue Rise, 14% Profit Drop on Pricing Pressures
● Jan 21, 2026
Dr. Reddy’s Laboratories Ltd. (NSE: DRREDDY), the Indian drugmaker, on Wednesday reported a modest rise in third-quarter revenue but a...
